The BEAM Alliance – Biotechs from Europe innovating in Antimicrobial Resistance - brings together 37 companies from ten countries to accelerate progress in dealing with drug-resistant infections
Europe’s pharma industry says the €2.2B cut to Horizon 2020 is misguided, while scientists and MEPs declare themselves happy, for the most part, that the cut is less than the €2.7B originally proposed
A complete ban on animal research would be premature and risk chasing biomedical research out of Europe the Commission says in response to the ‘Stop Vivisection’ European Citizen’s Initiative
Following pressure from the EU Ombudsman, the Commission has responded with a list of changes to the way it recruits experts who advise on legislation. But there is nothing to ensure overall balance, NGOs say
Since its 2014 launch the SME instrument has attracted applications from across Europe. But the quality is low, with only 12% passing the quality threshold. Bernd Reichert, head of unit at the Executive Agency for SMEs, offers tips for success
Following tough negotiations, the European Commission has announced it will cut €500M less from the Horizon 2020 research programme, after additional money is found in the EU budget
After all the promises about lower fees, small companies are in danger of being priced out of Europe’s new patent regime, complains Eurochambres in a letter to the EU industry chief
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.